VALENCIA, Calif., Dec. 1, 2011 /PRNewswire/ -- Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in the United States and Canada for Neptune™*, the world's first and only swimmable, waterproof sound processor.
Intended for swimming and bathing, Neptune is designed to help cochlear implant recipients hear in and out of the water. Recipients using other products on the market remove their processor when they swim or bathe, which means they miss out on important safety instructions and opportunities for language development because they are not hearing during those times.
Developed for all weather, terrain, ages and lifestyles, Neptune allows recipients to enjoy an abundance of water and sports activities thanks to its durable, waterproof design. Parents of pediatric recipients will appreciate the bonding and learning that comes with hearing during bath time, as well as the safety of hearing in the pool.
Designed after the chic styling of popular consumer electronics, the lightweight Neptune processor also features the industry's first freestyle™ design, allowing recipients to hear the world of sound with the comfort and beauty of nothing on the ear. Neptune's freestyle design is a new wearing category for the cochlear implant industry, giving recipients the ability to choose their wearing style. With the variety of convenient accessories, recipients can wear the Neptune processor anywhere and way they choose, such as in the hair, on an arm, under a collar, in a pocket-a high level of flexibility not available in the market until now. Neptune also comes in a wide range of fashion-forward colors for matching it to wardrobes or showing it off.
And for those who prefer a more discreet look, it can also be easily tucked away. Parents will appreciate the many features included to ensure that Neptune is the perfect choice for small children, including removable controls that make it tamper-proof so that children can always hear their best.
Advanced Bionics was able to develop these industry firsts without compromising hearing performance. Neptune is fully compatible with the most advanced hearing technology, including ClearVoice™, HiRes Fidelity 120™ and AutoSound™, which are only available from AB.* These sophisticated sound processing strategies are designed to deliver the best hearing performance in real-world environments where recipients would otherwise struggle, such as busy offices, loud playgrounds, music recitals and crowded restaurants.
Neptune garnered an enthusiastic response from the cochlear implant professional community when it was announced at this year's European Symposium on Pediatric Cochlear Implantation (ESPCI) in Athens, Greece and the 13th Symposium on Cochlear Implants in Children that took place in Chicago, IL, USA.
For more information about Neptune, contact a local Advanced Bionics representative or visit www.advancedbionics.com.
About Advanced Bionics
Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best.
AB offers the most sophisticated cochlear implant system on the market, the HiResolution™ Bionic Ear System, with five times more sound resolution than its competitors, designed to help recipients hear in noisy settings and enjoy the full dimensions of music.
With sales in over 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB's talented group of technologists and professionals from all over the world are driven to succeed, work with integrity and stay firmly committed to quality.
To learn more about AB and its innovative cochlear implant technology, please visit www.advancedbionics.com.
*Neptune is pending regulatory approval in markets outside of the United States and Canada. ClearVoice is pending regulatory approval in the United States. HiRes Fidelity 120 is not approved for pediatric use in the United States.